Advances in Liposomes for Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 720
Special Issue Editors
2. Institute for Chemical Engineering Sciences, Foundation for Research and Technology Hellas, FORTH/ICE-HT, Stadiou Street, 26510 Platani-Rio, Greece
Interests: targeted drug delivery; nanomedicines; liposome technology; lipid-based formulations
Special Issues, Collections and Topics in MDPI journals
Interests: liposomes; drug delivery; 2D nanomaterials; biodegradable polymers
Special Issues, Collections and Topics in MDPI journals
Interests: targeted drug delivery; tumor biology; liposomes and bioinspired nanocarriers; local drug delivery systems
Special Issue Information
Dear Colleagues,
Liposomes are small spherical vesicular structures composed of one or more phospholipid bilayers. Liposomal drug delivery systems possess specific features, including nano size, biodegradability, hydrophobic/hydrophilic characteristics, biocompatibility, and low or no toxicity and immunogenicity, which can all lead to considerable efficacy in treating various types of diseases. The rationale for developing liposomal-based drug delivery systems is to improve the therapeutic efficacy of drugs by reducing drug toxicity, improving drug solubility and stability, enhancing drug delivery to specific targets, and/or increasing their permeation across biological barriers. The diverse applications of liposomes as carriers for the delivery of drugs and other molecules have been attributed to the physicochemical and biophysical characteristics of the liposomal membrane and especially of the vesicle surface.
This Special Issue welcomes studies that include (but are not limited to) all aspects of liposomal drug delivery systems including their design, development, and characterizations as well as their pharmacodynamic and pharmacokinetic properties and their use as strategies for the prevention or treatment of medical conditions such as cancer, infection, inflammation, oxidant-induced tissue injuries, dermatological diseases, etc. Original research articles and comprehensive reviews are especially welcome.
Prof. Dr. Sophia G. Antimisiaris
Dr. Athanasios Skouras
Dr. Antonia Marazioti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liposomes
- drug delivery
- liposome-based therapeutics
- controlled release
- liposome technology
- encapsulation
- liposome stability
